All News #Library
Rare Diseases
EU Grant Orphan Status to Sumitomo`s Nuvisertib for Myelofibrosis
30 Jul 2025 //
PR NEWSWIRE
Sumitomo Pharma America: Nuvisertib (TP-3654) Gets FDA Fast Track
12 Jun 2025 //
PR NEWSWIRE
Sumitomo, NCI Partner to Advance Enzomenib Cancer Study
14 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support